0002002665-26-000004.txt : 20261008 0002002665-26-000004.hdr.sgml : 20261008 20261008135316 ACCESSION NUMBER: 0002002665-26-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261008 DATE AS OF CHANGE: 20261008 EFFECTIVENESS DATE: 20261008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GelSana Therapeutics, Inc. CENTRAL INDEX KEY: 0002002665 ORGANIZATION NAME: EIN: 853369265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-498739 FILM NUMBER: 261449409 BUSINESS ADDRESS: STREET 1: 12635 E MONTVIEW BLVD STE 216 CITY: AURORA STATE: CO ZIP: 80045 BUSINESS PHONE: (216) 502-0901 MAIL ADDRESS: STREET 1: 12635 E MONTVIEW BLVD STE 216 CITY: AURORA STATE: CO ZIP: 80045 D/A 1 primary_doc.xml X0708 D/A LIVE 0002002665 GelSana Therapeutics, Inc. 12635 E MONTVIEW BLVD STE 326 AURORA CO COLORADO 80045 (216) 502-0901 DELAWARE None None Corporation true Melissa Krebs c/o GelSana Therapeutics, Inc. 12635 E Montview Blvd Ste 326 Aurora CO COLORADO 80045 Executive Officer Director Mike Freeman c/o GelSana Therapeutics, Inc. 12635 E Montview Blvd Ste 326 Aurora CO COLORADO 80045 Director Diana Verrilli c/o GelSana Therapeutics, Inc. 12635 E Montview Blvd Ste 326 Aurora CO COLORADO 80045 Director Biotechnology Decline to Disclose 06b true 0002002665-26-000003 2023-11-20 true true false 0 4931726 4352701 579025 Total Amount Sold includes $1,681,751.88 of cancellation of convertible promissory notes and $2,670,950.03 of new cash. false 33 0 0 0 false GelSana Therapeutics, Inc. /s/ Melissa Krebs Melissa Krebs President 2026-10-08